Furthermore, patients with oncogene-addicted NSCLC, e.g., ALK, EGFR and STK11, did not benefit from IC blockade therapy, probably because of the “cold” nature of these tumors [29,30,31,32,33,34]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.